STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] CeriBell, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

CeriBell, Inc. filed a Form 144 notifying the proposed sale of 11,112 common shares via Fidelity Brokerage Services on or about 09/04/2025 on the NASDAQ. The filing reports an aggregate market value of $134,609.87 against 36,663,968 shares outstanding, indicating the shares represent approximately 0.03% of the outstanding common stock. The shares arise from option exercises: 1,472 shares from an option granted 07/07/2021 and 9,640 shares from an option granted 02/16/2023, with cash payment recorded on 09/04/2025. The filer reports no sales in the prior three months. The form contains standard representations about material nonpublic information and signature attestation.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider sale from exercised options; immaterial to market capitalization but relevant for short-term float.

The filing documents a planned sale of 11,112 shares worth $134,609.87, which is roughly 0.03% of the issuer's 36.66 million shares outstanding. These shares result from option exercises granted in 2021 and 2023 and will be sold through Fidelity on NASDAQ. From a capital-structure perspective, the amount is negligible relative to total outstanding shares and unlikely to move the stock price materially. The disclosure complies with Rule 144 timeliness and includes the standard attestation regarding material nonpublic information.

TL;DR: Filing meets Rule 144 disclosure norms; exercise-and-sale indicates routine insider liquidity, not an unusual governance event.

The notice indicates securities acquired via options and being sold shortly after exercise with cash payment recorded. The filer discloses no related sales in the past three months and includes the required attestations. This is a routine compliance disclosure showing an insider monetizing vested equity rather than signaling governance changes or unexpected departures.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

476.68M
29.22M
10.43%
84.44%
3.61%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE